AstraZeneca (MSC-1 Clinical-Stage Antibody Asset in Toronto, Canada) is Buildings and Property in Canada that focus on clinical stage business. They cover business area such as clinical stage, anti-lif monoclonal antibody asset, Toronto, Canada.
-
Clinical Stage
-
101 College Street
TMDT 11-301
Toronto, Ontario
Canada
Private
clinical stageanti-lif monoclonal antibody assetTorontoCanada
* We use standard office opening hours in near AstraZeneca (MSC-1 Clinical-Stage Antibody Asset in Toronto, Canada)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AstraZeneca (MSC-1 Clinical-Stage Antibody Asset In Toronto, Canada) is Buildings and Property business from Canada that founded in - ( years old in ), AstraZeneca (MSC-1 Clinical-Stage Antibody Asset in Toronto, Canada) business is focusing on Clinical Stage.
AstraZeneca (MSC-1 Clinical-Stage Antibody Asset in Toronto, Canada) headquarter office and corporate office address is located in 101 College Street TMDT 11-301 Toronto, Ontario Canada.
AstraZeneca (MSC-1 Clinical-Stage Antibody Asset in Toronto, Canada) was founded in Canada.
In , AstraZeneca (MSC-1 Clinical-Stage Antibody Asset in Toronto, Canada) is currently focus on clinical stage sector.
Above is snippet of Google Trends for "clinical stage" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AstraZeneca (MSC-1 Clinical-Stage Antibody Asset in Toronto, Canada), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
